Profile
| Metric | Value |
|---|---|
| Full Name | Stevanato Group S.p.A. |
| Ticker | NYSE: STVN |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Country | Italy |
| IPO | |
| Indexes | Not included |
| Website | stevanatogroup.com |
| Employees | 5,521 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $21.77 | |
| Price, 1D Change | +0.83% | |
| Market Cap | $6B | |
| TTM Dividend Yield | 0.28% | |
| PE Ratio | 38.27 | |
| Beta | 0.72 | |
| Revenue | $1B | |
| Revenue, 1Y Change | +1.78% | |
| EPS | $0.47 | |
| EPS, 1Y Change | -20.94% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.06 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $0.47 | |
| EPS Estimate | $0.61 | |
| EPS Est. Change | +29.80% | |
| Revenue | $1.19B | |
| Revenue Estimate | $1.17B | |
| Revenue Est. Change | -1.71% | |
| Current Price | $21.77 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.64 | $0.59 | -7.16% | |
| $0.50 | $0.47 | -5.83% | |
| $0.61 | N/A | +29.80% | |
| $0.74 | N/A | +57.00% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.18B | $1.17B | -0.97% | |
| $1.10B | $1.19B | +8.94% | |
| $1.17B | N/A | -1.71% | |
| $1.29B | N/A | +7.71% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -9.06% | |
| Price, 3Y | +8.85% | |
| Market Cap, 1Y | -9.03% | |
| Market Cap, 3Y | +12.26% | |
| Revenue, 1Y | +1.78% | |
| Revenue, 3Y | +19.72% | |
| EPS, 1Y | -20.94% | |
| EPS, 3Y | -21.67% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $21.77 | |
| SMA 200 | $23.39 | |
| SMA 200 vs Price | +7.45% | |
| SMA 50 | $22.41 | |
| SMA 50 vs Price | +2.93% | |
| Beta | 0.72 | |
| ATR | $0.86 | |
| 14-Day RSI | 53.64 | |
| 10-Day Volatility | 24.96% | |
| 1-Year Volatility | 48.43% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.06 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 0.27% | |
| Total Dividend | $0.06 | |
| Dividends Paid | $15.64M | |
| Payout Ratio | 12.28% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $1.19B | |
| EPS | $0.47 | |
| Gross Profit | $315.93M | |
| Gross Margin | 26.46% | |
| Operating Profit | $167.30M | |
| Operating Margin | 14.01% | |
| Net Income | $127.39M | |
| Net Margin | 10.67% | |
| EBITDA | $251.71M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.31 | |
| Current Ratio | 1.84 | |
| Quick Ratio | 1.33 | |
| - | ||
| F-Score | 6 | |
| Altman Z-Score | 4.66 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 38.27 | |
| PS Ratio | 4.59 | |
| PB Ratio | 3.52 | |
| EV/EBITDA | 21.29 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $1.46B | |
| Cash & Equivalents | $102.26M | |
| Total Assets | $2.41B | |
| Current Assets | $915.83M | |
| Total Liabilities | $957.25M | |
| Current Liabilities | $496.85M | |
| Total Debt | $444.20M | |
| Short Term Debt | $116.48M | |
| Accounts Payable | $240.39M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $1.07B | |
| Operating Expenses | $148.63M | |
| Cost Of Goods Sold | $878.29M | |
| SG&A | $128.29M | |
| D&A | $84.41M | |
| Interest Expense | $0.00 | |
| Income Tax | $46.00M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $168.50M | |
| CFI | -$335.56M | |
| CFF | $198.19M | |
| Capex | $339.19M | |
| Free Cash Flow | -$170.69M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Morgan Stanley | → | |
| Morgan Stanley | → | |
| UBS | → | |
| Wolfe Research | ||
| B of A Securities | → | |
| Citigroup | → | |
| Morgan Stanley | → | |
| Morgan Stanley | → | |
| Stephens & Co. | → | |
| Morgan Stanley | → |
Analyst sentiment
Institutional ownership
Screeners with STVN
Data Sources & References
- STVN Official Website www.stevanatogroup.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1849853/000119312525269425/0001193125-25-269425-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1849853/000095017025034633/0000950170-25-034633-index.htm
- STVN Profile on Yahoo Finance finance.yahoo.com/quote/STVN
- STVN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/stvn
FAQ
What is the ticker symbol for Stevanato Group S.p.A.?
The ticker symbol for Stevanato Group S.p.A. is NYSE:STVN
Does Stevanato Group S.p.A. pay dividends?
Yes, Stevanato Group S.p.A. pays dividends. The last payment was $0.06, with an ex-dividend date on June 5, 2025
What sector is Stevanato Group S.p.A. in?
Stevanato Group S.p.A. is in the Healthcare sector
What industry is Stevanato Group S.p.A. in?
Stevanato Group S.p.A. is in the Medical Instruments & Supplies industry
What country is Stevanato Group S.p.A. based in?
Stevanato Group S.p.A. is headquartered in Italy
When did Stevanato Group S.p.A. go public?
Stevanato Group S.p.A. initial public offering (IPO) was on July 16, 2021
Is Stevanato Group S.p.A. in the S&P 500?
No, Stevanato Group S.p.A. is not included in the S&P 500 index
Is Stevanato Group S.p.A. in the NASDAQ 100?
No, Stevanato Group S.p.A. is not included in the NASDAQ 100 index
Is Stevanato Group S.p.A. in the Dow Jones?
No, Stevanato Group S.p.A. is not included in the Dow Jones index
When was Stevanato Group S.p.A. last earnings report?
Stevanato Group S.p.A.'s most recent earnings report was on November 6, 2025
When does Stevanato Group S.p.A. report earnings?
The next expected earnings date for Stevanato Group S.p.A. is March 5, 2026